InnovAge director granted 8,539 RSUs

FONTNEAU PATRICIA reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/02/2026 - 04:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

FONTNEAU PATRICIA reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. director Patricia Fontneau received a grant of 8,539 Restricted Stock Units, or RSUs, that will settle in shares of common stock. The award was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase. After this grant, Fontneau holds 70,664 shares directly. The RSUs vest in full on June 30, 2027, provided she continues her service with the company.

Insider Trade Summary

Grant/Award: 8,539 shares

Grant/Award 1 txn

Insider FONTNEAU PATRICIA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value	8,539	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.001 par value — 70,664 shares (Direct)

Holdings Before and After: Common Stock, $0.001 par value, 62,125 to 70,664 shares (Direct)

Footnotes (1)

1. F1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 8,539 units Holding after transaction: 70,664 shares Grant price: $0.00 per share +1 more

4 metrics

RSUs granted 8,539 units Restricted Stock Units awarded to director on July 1, 2026

Holding after transaction 70,664 shares Total InnovAge common shares held directly after grant

Grant price $0.00 per share Compensation-related RSU award, not open-market purchase

Vesting date June 30, 2027 RSUs vest in full if service with issuer continues

Key Terms

Restricted Stock Units ("RSUs"), vest in full, Grant, award, or other acquisition

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"and will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did InnovAge (INNV) director Patricia Fontneau report in this Form 4?

Patricia Fontneau reported receiving 8,539 Restricted Stock Units as compensation. These RSUs will convert into InnovAge common shares upon vesting, increasing her equity stake if she remains with the company through the full vesting date.

How many InnovAge (INNV) shares does Patricia Fontneau hold after this RSU grant?

After the reported grant, Patricia Fontneau holds 70,664 InnovAge common shares directly. This total includes the newly awarded RSUs, which will settle in stock once they vest, assuming she continues her service with InnovAge through the vesting date.

When do Patricia Fontneau’s InnovAge (INNV) RSUs from this filing vest?

The 8,539 Restricted Stock Units vest in full on June 30, 2027. Vesting is contingent on Patricia Fontneau’s continued service with InnovAge, meaning she must remain in her role through that date for the RSUs to convert into common shares.

Was Patricia Fontneau’s InnovAge (INNV) RSU grant an open-market stock purchase?

No, the RSU grant was not an open-market purchase. The Form 4 lists the transaction code as a grant or award at a price of $0.00 per share, indicating compensation rather than stock bought on the public market by the director.

What type of security did InnovAge (INNV) grant to Patricia Fontneau in this transaction?

InnovAge granted Patricia Fontneau Restricted Stock Units that will be settled in common stock. These RSUs represent a right to receive InnovAge shares in the future, subject to vesting conditions tied to her continued service with the company through June 30, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FONTNEAU PATRICIA

(Last) (First) (Middle)

8950 E. LOWRY BOULEVARD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/01/2026		A		8,539(1)	A	$0	70,664	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)